NuGen Medical Devices Inc
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also pro… Read more
NuGen Medical Devices Inc (NGMDF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.122x
Based on the latest financial reports, NuGen Medical Devices Inc (NGMDF) has a cash flow conversion efficiency ratio of 0.122x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.05 Million) by net assets ($-8.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NuGen Medical Devices Inc - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how NuGen Medical Devices Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
NuGen Medical Devices Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NuGen Medical Devices Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sammakorn Public Company Limited
BK:SAMCO
|
-0.017x |
|
AIxCrypto Holdings, Inc.
NASDAQ:AIXC
|
-0.056x |
|
Wonpung Mulsan Co.Ltd
KQ:008290
|
-0.087x |
|
North Eastern Carrying Corporation Limited
NSE:NECCLTD
|
0.031x |
|
CGX Energy Inc
PINK:CGXEF
|
-0.235x |
|
Kelso Technologies Inc
PINK:KIQSF
|
0.066x |
|
Revive Therapeutics Ltd
OTCQB:RVVTF
|
-0.034x |
|
Proodeftiki S.A.
AT:PRD
|
-0.022x |
Annual Cash Flow Conversion Efficiency for NuGen Medical Devices Inc (2020–2024)
The table below shows the annual cash flow conversion efficiency of NuGen Medical Devices Inc from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-5.67 Million | $-4.71 Million | 0.831x | -74.50% |
| 2023-12-31 | $-2.06 Million | $-6.71 Million | 3.259x | +51.03% |
| 2022-12-31 | $-2.26 Million | $-4.88 Million | 2.158x | +187.35% |
| 2021-12-31 | $1.66 Million | $-4.10 Million | -2.470x | -222.69% |
| 2020-12-31 | $-692.25K | $-1.39 Million | 2.013x | -- |